coward pharmacy limited
coward pharmacy limited Company Information
Company Number
03911791
Website
-Registered Address
48 maiden view, lanchester, durham, DH7 0BF
Industry
Dispensing chemist in specialised stores
Telephone
-
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
sri kanaparthy limited 100%
coward pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of COWARD PHARMACY LIMITED at £420.8k based on a Turnover of £1.5m and 0.28x industry multiple (adjusted for size and gross margin).
coward pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of COWARD PHARMACY LIMITED at £45.1k based on an EBITDA of £11.1k and a 4.05x industry multiple (adjusted for size and gross margin).
coward pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of COWARD PHARMACY LIMITED at £171k based on Net Assets of £74.5k and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Coward Pharmacy Limited Overview
Coward Pharmacy Limited is a live company located in durham, DH7 0BF with a Companies House number of 03911791. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in January 2000, it's largest shareholder is sri kanaparthy limited with a 100% stake. Coward Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £1.5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Coward Pharmacy Limited Health Check
Pomanda's financial health check has awarded Coward Pharmacy Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
5 Weak
Size
annual sales of £1.5m, make it smaller than the average company (£12m)
- Coward Pharmacy Limited
£12m - Industry AVG
Growth
3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (5.3%)
- Coward Pharmacy Limited
5.3% - Industry AVG
Production
with a gross margin of 27.1%, this company has a comparable cost of product (31.7%)
- Coward Pharmacy Limited
31.7% - Industry AVG
Profitability
an operating margin of 0.7% make it less profitable than the average company (3.4%)
- Coward Pharmacy Limited
3.4% - Industry AVG
Employees
with 9 employees, this is below the industry average (81)
9 - Coward Pharmacy Limited
81 - Industry AVG
Pay Structure
on an average salary of £22k, the company has an equivalent pay structure (£22k)
- Coward Pharmacy Limited
£22k - Industry AVG
Efficiency
resulting in sales per employee of £168.8k, this is more efficient (£138.8k)
- Coward Pharmacy Limited
£138.8k - Industry AVG
Debtor Days
it gets paid by customers after 64 days, this is later than average (31 days)
- Coward Pharmacy Limited
31 days - Industry AVG
Creditor Days
its suppliers are paid after 72 days, this is close to average (69 days)
- Coward Pharmacy Limited
69 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Coward Pharmacy Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Coward Pharmacy Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 74.8%, this is a higher level of debt than the average (61.6%)
74.8% - Coward Pharmacy Limited
61.6% - Industry AVG
COWARD PHARMACY LIMITED financials
Coward Pharmacy Limited's latest turnover from March 2023 is estimated at £1.5 million and the company has net assets of £74.5 thousand. According to their latest financial statements, Coward Pharmacy Limited has 9 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | ||||||||||||||
| Interest Receivable | ||||||||||||||
| Pre-Tax Profit | ||||||||||||||
| Tax | ||||||||||||||
| Profit After Tax | ||||||||||||||
| Dividends Paid | ||||||||||||||
| Retained Profit | ||||||||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | 9 | 9 | 9 | 7 | 11 | 11 | ||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 28,484 | 29,463 | 20,009 | 22,483 | 26,262 | 26,879 | 32,203 | 31,753 | 34,840 | 35,592 | 41,814 | 44,042 | 37,022 | 43,555 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 3,000 | 4,500 | 6,000 | 7,500 | 9,000 | 10,500 | 12,000 | 13,500 | 15,000 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 28,484 | 29,463 | 20,009 | 22,483 | 26,262 | 29,879 | 36,703 | 37,753 | 42,340 | 44,592 | 52,314 | 56,042 | 50,522 | 58,555 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 54,000 | 54,000 | 69,000 | 69,000 | 68,840 | 68,753 | 74,800 | 73,952 | 84,869 |
| Trade Debtors | 267,303 | 278,338 | 288,000 | 256,679 | 205,010 | 106,557 | 49,452 | 85,544 | 294,240 | 259,682 | 252,364 | 244,334 | 250,142 | 264,285 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 23,219 | 194,839 | 169,428 | 0 | 0 | 0 | 0 | 0 | 13,748 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 58,277 | 198,992 | 8,384 | 59,717 | 66,336 | 22,373 | 62,486 | 113,940 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 11,660 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 267,303 | 278,338 | 288,000 | 256,679 | 205,010 | 195,436 | 356,568 | 522,964 | 371,624 | 388,239 | 387,453 | 341,507 | 386,580 | 476,842 |
| total assets | 295,787 | 307,801 | 308,009 | 279,162 | 231,272 | 225,315 | 393,271 | 560,717 | 413,964 | 432,831 | 439,767 | 397,549 | 437,102 | 535,397 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 15,402 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 221,288 | 242,305 | 193,156 | 210,186 | 118,479 | 36,047 | 81,954 | 166,427 | 173,455 | 177,984 | 189,421 | 173,468 | 81,839 | 289,794 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137,208 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 3,500 | 36,279 | 126,599 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 221,288 | 242,305 | 193,156 | 210,186 | 118,479 | 54,949 | 118,233 | 293,026 | 173,455 | 177,984 | 189,421 | 173,468 | 219,047 | 289,794 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 357 | 1,249 | 4,170 | 3,642 | 4,265 | 4,318 | 2,500 | 3,050 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 357 | 1,249 | 4,170 | 3,642 | 4,265 | 4,318 | 2,500 | 3,050 |
| total liabilities | 221,288 | 242,305 | 193,156 | 210,186 | 118,479 | 54,949 | 118,590 | 294,275 | 177,625 | 181,626 | 193,686 | 177,786 | 221,547 | 292,844 |
| net assets | 74,499 | 65,496 | 114,853 | 68,976 | 112,793 | 170,366 | 274,681 | 266,442 | 236,339 | 251,205 | 246,081 | 219,763 | 215,555 | 242,553 |
| total shareholders funds | 74,499 | 65,496 | 114,853 | 68,976 | 112,793 | 170,366 | 274,681 | 266,442 | 236,339 | 251,205 | 246,081 | 219,763 | 215,555 | 242,553 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 5,324 | 6,145 | 5,604 | 5,773 | 6,272 | 7,339 | 6,342 | 6,533 | 3,394 | |||||
| Amortisation | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | |||||
| Tax | ||||||||||||||
| Stock | 0 | 0 | 0 | 0 | -54,000 | 0 | -15,000 | 0 | 160 | 87 | -6,047 | 848 | -10,917 | 84,869 |
| Debtors | -11,035 | -9,662 | 31,321 | 51,669 | 75,234 | -114,515 | -10,681 | -39,268 | 34,558 | 7,318 | 8,030 | -5,808 | -27,891 | 278,033 |
| Creditors | -21,017 | 49,149 | -17,030 | 91,707 | 82,432 | -45,907 | -84,473 | -7,028 | -4,529 | -11,437 | 15,953 | 91,629 | -207,955 | 289,794 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | -3,500 | -32,779 | -90,320 | 126,599 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | -357 | -892 | -2,921 | 528 | -623 | -53 | 1,818 | -550 | 3,050 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -137,208 | 137,208 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | ||||||||||||||
| cash flow from financing | ||||||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | -58,277 | -140,715 | 190,608 | -51,333 | -6,619 | 43,963 | -40,113 | -51,454 | 113,940 |
| overdraft | 0 | 0 | 0 | 0 | -15,402 | 15,402 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 15,402 | -73,679 | -140,715 | 190,608 | -51,333 | -6,619 | 43,963 | -40,113 | -51,454 | 113,940 |
coward pharmacy limited Credit Report and Business Information
Coward Pharmacy Limited Competitor Analysis
Perform a competitor analysis for coward pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in DH7 area or any other competitors across 12 key performance metrics.
coward pharmacy limited Ownership
COWARD PHARMACY LIMITED group structure
Coward Pharmacy Limited has no subsidiary companies.
coward pharmacy limited directors
Coward Pharmacy Limited currently has 2 directors. The longest serving directors include Mrs Vijaya Kanaparthy (Dec 2018) and Mr Sri Kanaparthy (Dec 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Vijaya Kanaparthy | England | 41 years | Dec 2018 | - | Director |
| Mr Sri Kanaparthy | 43 years | Dec 2018 | - | Director |
P&L
March 2023turnover
1.5m
+14%
operating profit
11.1k
0%
gross margin
27.2%
-1.29%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
74.5k
+0.14%
total assets
295.8k
-0.04%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
coward pharmacy limited company details
company number
03911791
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
January 2000
age
24
incorporated
UK
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
last accounts submitted
March 2023
address
48 maiden view, lanchester, durham, DH7 0BF
accountant
-
auditor
-
coward pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to coward pharmacy limited.
coward pharmacy limited Companies House Filings - See Documents
| date | description | view/download |
|---|
